Extremely favourable risk reward trade. Stoploss at 503, just above 200 week moving average. Extremely important level for any stock. It has broken the resistance level of 500 and may soon breach 100 DMA. First target is 540 and second target is 576. This trade does derive comfort from the general breakout of pharma sector in India.